age1
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
age1 is explicitly described as a venture capital firm focused on founder-led longevity biotech companies. OpenDrugs is a longevity-focused, AI-native research and data platform, so this is a direct thematic capital fit at proof-of-concept stage.